New Class of Antibiotics

News   Apr 09, 2018 | Original story from University of Illinois at Chicago

 
New Class of Antibiotics

ODLs (yellow) bind to a site on the ribosome not used by other antibiotics. Location of this site is shown here relative to the sites of other known antibiotics, such as negamycin (green), tetracycline (dark blue), aminoglycoside antibiotic paromomycin (red) and streptomycin (light blue). Credit: UIC/Yury Polikanov, et al

 
 
 

RELATED ARTICLES

Compound as Effective as FDA-Approved Drugs Against Life-Threatening Infections

News

Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.

READ MORE

Chemists Design 'Mini-ecosystems' to Test Drug Function

News

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.

READ MORE

Targeting the Engine Room of the Cancer Cell

News

Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy